TY - JOUR
T1 - The role of high serum triglyceride levels on pancreatic necrosis development and related complications
AU - Hidalgo, Nils Jimmy
AU - Pando Rau, Elizabeth Paola
AU - Alberti, Piero
AU - Mata, Rodrigo
AU - Fernandes, Nair
AU - Adell, Montse
AU - Villasante, Sara
AU - Blanco, Laia
AU - Balsells, Joaquim
AU - Charco, Ramon
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/2/24
Y1 - 2023/2/24
N2 - Background: The relevance of elevated serum triglyceride (TG) levels in the early stages of acute pancreatitis (AP) not induced by hypertriglyceridemia (HTG) remains unclear. Our study aims to determine the role of elevated serum TG levels at admission in developing pancreatic necrosis. Methods: We analyzed the clinical data collected prospectively from patients with AP. According to TG levels measured in the first 24 h after admission, we stratified patients into four groups: Normal TG (< 150 mg/dL), Borderline-high TG (150–199 mg/dL), High TG (200–499 mg/dL) and Very high TG (≥ 500 mg/dL). We analyzed the association of TG levels and other risk factors with the development of pancreatic necrosis. Results: A total of 211 patients were included. In the Normal TG group: 122, in Borderline-high TG group: 38, in High TG group: 44, and in Very high TG group: 7. Pancreatic necrosis developed in 29.5% of the patients in the Normal TG group, 26.3% in the Borderline-high TG group, 52.3% in the High TG group, and 85.7% in the Very high TG group. The trend analysis observed a significant association between higher TG levels and pancreatic necrosis (p = 0.001). A multivariable analysis using logistic regression showed that elevated TG levels ≥ 200 mg/dL (High TG and Very high TG groups) were independently associated with pancreatic necrosis (OR: 3.27, 95% CI − 6.27, p < 0.001). Conclusions: An elevated TG level at admission ≥ 200 mg/dl is independently associated with the development of pancreatic necrosis. The incidence of pancreatic necrosis increases proportionally with the severity of HTG.
AB - Background: The relevance of elevated serum triglyceride (TG) levels in the early stages of acute pancreatitis (AP) not induced by hypertriglyceridemia (HTG) remains unclear. Our study aims to determine the role of elevated serum TG levels at admission in developing pancreatic necrosis. Methods: We analyzed the clinical data collected prospectively from patients with AP. According to TG levels measured in the first 24 h after admission, we stratified patients into four groups: Normal TG (< 150 mg/dL), Borderline-high TG (150–199 mg/dL), High TG (200–499 mg/dL) and Very high TG (≥ 500 mg/dL). We analyzed the association of TG levels and other risk factors with the development of pancreatic necrosis. Results: A total of 211 patients were included. In the Normal TG group: 122, in Borderline-high TG group: 38, in High TG group: 44, and in Very high TG group: 7. Pancreatic necrosis developed in 29.5% of the patients in the Normal TG group, 26.3% in the Borderline-high TG group, 52.3% in the High TG group, and 85.7% in the Very high TG group. The trend analysis observed a significant association between higher TG levels and pancreatic necrosis (p = 0.001). A multivariable analysis using logistic regression showed that elevated TG levels ≥ 200 mg/dL (High TG and Very high TG groups) were independently associated with pancreatic necrosis (OR: 3.27, 95% CI − 6.27, p < 0.001). Conclusions: An elevated TG level at admission ≥ 200 mg/dl is independently associated with the development of pancreatic necrosis. The incidence of pancreatic necrosis increases proportionally with the severity of HTG.
KW - Acute pancreatitis
KW - Triglyceride
KW - Pancreatic necrosis
KW - Hypertriglyceridemia
KW - Acute pancreatitis
KW - Triglyceride
KW - Pancreatic necrosis
KW - Hypertriglyceridemia
KW - Acute pancreatitis
KW - Triglyceride
KW - Pancreatic necrosis
KW - Hypertriglyceridemia
UR - http://www.scopus.com/inward/record.url?scp=85148965598&partnerID=8YFLogxK
U2 - 10.1186/s12876-023-02684-9
DO - 10.1186/s12876-023-02684-9
M3 - Article
C2 - 36829113
SN - 1471-230X
VL - 23
JO - BMC Gastroenterology
JF - BMC Gastroenterology
M1 - 51
ER -